H.R. 8005 · 119th Congress

Stop Pills That Kill Act

Introduced on Mar 19, 2026 by Gabe Evans (R-CO-8). Latest action (Sep 16, 2026): Received in the Senate and Read twice and referred to the Committee on the Judiciary.

Stage
Passed one chamber
Introduced
Mar 19, 2026
Cosponsors
0
Policy area
Crime and Law Enforcement
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. Reported by committee
  3. Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To amend the Controlled Substances Act to prohibit certain acts related to fentanyl, analogues of fentanyl, and counterfeit substances, and for other purposes.

Subjects

  • Administrative law and regulatory procedures
  • Congressional oversight
  • Criminal procedure and sentencing
  • Drug trafficking and controlled substances
  • U.S. Sentencing Commission

Summary

By the Congressional Research Service (Introduced in House, Mar 19, 2026). Public domain.

Stop Pills That Kill Act

This bill increases criminal penalties for offenses relating to the manufacture of fentanyl or counterfeit substances. It also establishes requirements for federal agencies to address the use of counterfeit substances.

Specifically, the bill applies an increased criminal penalty for possessing, manufacturing, or distributing certain equipment or materials that are used to illegally manufacture fentanyl, an analogue of fentanyl, or a counterfeit substance (the increased penalty is currently limited to offenses involving methamphetamine).

The Drug Enforcement Administration must establish and implement a plan to address counterfeit fentanyl or methamphetamine substances through law enforcement action and education and prevention efforts. In addition, the Department of Justice must annually report on the collection of counterfeit fentanyl or methamphetamine substances by law enforcement and on related prosecutions.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Gabe EvansR-CO-8Sponsor

No cosponsors.

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Mar 19, 2026Introduced in House
  2. Mar 19, 2026Introduced in House
  3. Mar 19, 2026 · HouseReferred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. Mar 19, 2026 · HouseReferred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. Mar 19, 2026 · HouseReferred to the Subcommittee on Health.
  6. Jul 15, 2026 · HouseSubcommittee Consideration and Mark-up Session Held
  7. Jul 15, 2026 · HouseForwarded by Subcommittee to Full Committee (Amended) by Voice Vote.
  8. Jul 20, 2026 · HouseCommittee Consideration and Mark-up Session Held
  9. Jul 21, 2026 · HouseCommittee Consideration and Mark-up Session Held
  10. Jul 21, 2026 · HouseOrdered to be Reported in the Nature of a Substitute by the Yeas and Nays: 43 - 6.
  11. Sep 15, 2026 · HouseMr. Guthrie moved to suspend the rules and pass the bill, as amended.
  12. Sep 15, 2026 · HouseConsidered under suspension of the rules. (consideration: CR H5674-5676)
  13. Sep 15, 2026 · HouseDEBATE - The House proceeded with forty minutes of debate on H.R. 8005.
  14. Sep 15, 2026Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
  15. Sep 15, 2026 · HouseOn motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5674-5675)
  16. Sep 15, 2026 · HouseMotion to reconsider laid on the table Agreed to without objection.
  17. Sep 15, 2026 · HouseThe title of the measure was amended. Agreed to without objection.
  18. Sep 16, 2026 · SenateReceived in the Senate and Read twice and referred to the Committee on the Judiciary.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. American Society of Health-System Pharmacists1 report
    $260K reported (all issues)Federal contractor: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS INC$350.5K in contracts, FY2026AI match · 100%
  2. Southeast Georgia Hospital System1 report
    $24K reported (all issues)

Reports filed in 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 5, 2026 · loaded Oct 5, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.